Stock listing

Abbvie Inc.

Selected listing: ABBV · BMV · MXN · MX

Abbvie Inc. (BMV:ABBV), Health Technology. Latest release Oct 5, 2026: AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates…

ABBV:BMVMXNMXUpdated October 2, 2026

Ticker: BMV:ABBV
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: BMV
Currency: MXN

About Abbvie Inc.

The company is involved in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies. Abbvie aims to address complex health challenges and improve patient outcomes through its diverse portfolio of products.

Latest news from Abbvie Inc.

AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

October 5, 2026

AbbVie Presents Long-Term RINVOQ® (upadacitinib) Data Showing Continued Repigmentation in Non-Segmental Vitiligo

October 1, 2026

AbbVie to Host Third-Quarter 2026 Earnings Conference Call

October 1, 2026

AbbVie Presents Detailed Phase 1 Data for ABBV-295, a Long-Acting Amylin Analog, Demonstrating Favorable Tolerability and Pharmacokinetic Profile at EASD 2026

September 30, 2026

AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress

September 30, 2026

All Abbvie Inc. news →

Events

Replays

AbbVie Inc. (ABBV) Q2 2026 Earnings Call
Fri, Jul 31, 2026 · 09:00 AM ET
Watch
AbbVie Inc. (ABBV) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 09:00 AM ET
Watch
AbbVie Inc. (ABBV) Q4 2025 Earnings Call
Wed, Feb 04, 2026 · 09:00 AM ET
Watch

Research Abbvie Inc.

Abbvie Inc. company profile

View the public company page for Abbvie Inc. on 6ix.

Abbvie Inc. news

Read company news and market updates connected to Abbvie Inc..

Abbvie Inc. investor events

Find investor webinars, events, and replay context for Abbvie Inc..